If elevated BRCA1 hypermethylation levels in blood cells constitute a risk factor for TNBC (and ovarian cancer) development and are present prior to tumorigenesis, these observations raise important questions regarding potential screening, prevention and early detection, requiring development of more sensitive assays for patient classification. Here, BRCA1 is linked to ovarian cancer.